RYR2 and atrial fibrillation: In atrial fibrillation-remodelled hearts, we recently confirmed that inhibition of increased RyR2-mediated [Ca2+]SR leakage by dantrolene can suppress CaT/APD alternans and thereby decrease AF vulnerability [32].